Showing results (231-240 of 330) with videos related to
Sort By:
Pageof 33
Current Pharmaceutical Design|January 5, 2013
PCSK9 inhibition - a novel mechanism to treat lipid disorders?Maciej Banach, Manfredi Rizzo, Milan Obradovic, et al.Current Issues in Molecular Biology|October 28, 2025
Obesity as a Multifactorial Chronic Disease: Molecular Mechanisms, Systemic Impact, and Emerging Digital InterventionsEwelina Młynarska, Kinga Bojdo, Anna Bulicz, et al.Nutrients|September 13, 2025
Creatine Supplementation Combined with Exercise in the Prevention of Type 2 Diabetes: Effects on Insulin Resistance and SarcopeniaEwelina Młynarska, Klaudia Leszto, Kinga Katańska, et al.Nutrients|April 12, 2025
The Gut-Brain-Microbiota Connection and Its Role in Autism Spectrum DisordersEwelina Młynarska, Ewelina Barszcz, Emilian Budny, et al.International Journal of Molecular Sciences|July 13, 2024
From Atherosclerotic Plaque to Myocardial Infarction-The Leading Cause of Coronary Artery OcclusionEwelina Młynarska, Witold Czarnik, Piotr Fularski, et al.Nutrients|November 27, 2025
The Mediterranean Diet in Primary and Secondary Prevention of Coronary Heart Disease: Evidence and MechanismsEwelina Młynarska, Julia Kurcińska, Szymon Kurciński, et al.Heart (British Cardiac Society)|August 29, 2009
Lone atrial fibrillation: what do we know?Dariusz Kozlowski, Szymon Budrejko, Gregory Y H Lip, et al.Antioxidants (Basel, Switzerland)|June 27, 2024
Role of Uremic Toxins, Oxidative Stress, and Renal Fibrosis in Chronic Kidney DiseaseWeronika Frąk, Bartłomiej Dąbek, Marta Balcerczyk-Lis, et al.Expert Opinion on Investigational Drugs|November 27, 2009
Vernakalant hydrochloride for the treatment of atrial fibrillationDariusz Kozlowski, Szymon Budrejko, Gregory Y H Lip, et al.Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|September 30, 2006
[Evaluation of surgical treatment of mitral valve defect in patients with chronic renal failure]Jerzy Knopik, Maciej Banach, Marcin Barylski, et al.Pageof 33